APPLICATION
ANDA206815
TYPE
ANDA
ORIGINAL APPROVAL
2016-02-18
LATEST ACTION
2020-02-21
ROUTE
ORAL, RECTAL, ORAL, RECTAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
SODIUM POLYSTYRENE SULFONATEPrescription
SODIUM POLYSTYRENE SULFONATE 454GM/BOT · POWDER · ORAL, RECTAL
Approval history
2020-02-21Labeling · Supplement 1 · standardAP
2016-02-18UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.